Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
26.46 USD | -2.54% | -2.32% | -8.47% |
May. 23 | Supernus Pharmaceuticals Reports 'Clinical Utility' From Epilepsy Treatment Study | MT |
May. 23 | Transcript : Supernus Pharmaceuticals, Inc. - Special Call |
Official Publications
No official publication found
- Stock Market
- Equities
- SUPN Stock
- News Supernus Pharmaceuticals, Inc.
- Official Publications